XENETIC BIOSCIENCES, INC. Class of Warrant or Right, Outstanding
XENETIC BIOSCIENCES, INC. (XBIO) had Class of Warrant or Right, Outstanding of 800 shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-06
- 2026-06-30: Class of Warrant or Right, Outstanding 800.00 shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 800.00 shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 800.00 shares.
- 2018-09-30: Class of Warrant or Right, Outstanding 3.15M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 800.00 shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 800.00 shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 800.00 shares 10-Q · filed 2026-08-06 | |
| 2018-09-30 | 3.15M shares 10-Q · filed 2018-11-09 | |
| 2018-06-30 | 3.15M shares 10-Q · filed 2018-08-10 | |
| 2016-09-30 | 758.35K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 758.35K shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 13.03M shares 10-Q · filed 2016-05-16 | |
| 2015-12-31 | 758.35K shares 10-Q · filed 2016-11-14 | 13.03M shares 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |